Paul J. Pockros, Lennox Jeffers, Nezam Afdhal, Zachary D. Goodman, David Nelson, Robert G. Gish, K. Rajender Reddy, Robert Reindollar, Maribel Rodriguez‐Torres, Sarah Sullivan, Lawrence M. Blatt, Sima Faris‐Young – 26 February 2007 – Interferon‐γ1b (IFN‐γ1b) is a pleiotropic cytokine that displays antifibrotic, antiviral, and antiproliferative activity.

Koko Bate Aborsangaya, Iga Dembinski, Suresh Khatkar, Martin Prince Alphonse, Peter Nickerson, Julia D. Rempel – 26 February 2007 – The host immune response is a critical determinant in viral infection outcome. Epidemiological studies indicate that North American indigenous peoples are more resistant to chronic HCV infection than other populations. Due to the prominence of IL‐10 in chronic HCV infection, we investigated the genetic tendency to produce IL‐10 in Caucasian (CA) and First Nation (FN) populations.

Evangelos Cholongitas, Laura Marelli, Andrew Kerry, Marco Senzolo, David W. Goodier, Devaki Nair, Michael Thomas, David Patch, Andrew K. Burroughs – 23 February 2007 – Bilirubin (Bil) interferes with creatinine (Cr) measurement. Different laboratory methods are used to overcome this problem. Model for end‐stage liver disease (MELD) scoring incorporates Cr and is used to prioritize patients for liver transplantation. Thus, MELD scores may vary with different Cr measurements influencing patients' priority.

Jessica Tan, Anna S.F. Lok – 22 February 2007

James D. Perkins – 22 February 2007

Michael Olausson, Styrbjörn Friman, Gustaf Herlenius, Christian Cahlin, Ola Nilsson, Svante Jansson, Bo Wängberg, Håkan Ahlman – 22 February 2007 – Liver transplantation can be a therapeutic option for individual patients with neuroendocrine tumors metastatic only to the liver. In this consecutive series of 15 patients (5 multivisceral and 10 orthotopic liver transplantations) with well‐differentiated carcinoids, or endocrine pancreatic tumors, we allowed higher proliferation rate (Ki67 <10%), large tumor burden, and higher age than previous studies.

E. Sykes, J. F. Cosgrove, I. D. Nesbitt, C. B. O'Suilleabhain – 22 February 2007 – Noncardiogenic pulmonary edema in liver transplant recipients is usually secondary to TRALI (transfusion related acute lung injury) or liver ischemic‐reperfusion injury. If persistent, the resultant hypoxemia is associated with increased ventilator days, prolonged length of stay (intensive care and hospital) and increased 28‐day mortality.

Ismail Ben Mosbah, Marta Massip‐Salcedo, Izabel Fernández‐Monteiro, Carme Xaus, Ramon Bartrons, Olivier Boillot, Joan Roselló‐Catafau, Carmen Peralta – 22 February 2007 – This study investigates how the addition of trimetazidine (TMZ) and aminoimidazole‐4‐carboxamide ribonucleoside (AICAR) to University of Wisconsin (UW) solution protects steatotic livers. Steatotic and nonsteatotic livers were preserved for 24 hours at 4°C in UW and UW with TMZ and AICAR (separately or in combination) and then perfused ex vivo for 2 hours at 37°C.

Jens Rosenau, Nazanin Hooman, Johannes Hadem, Kinan Rifai, Matthias J. Bahr, Gunnar Philipp, Hans L. Tillmann, Juergen Klempnauer, Christian P. Strassburg, Michael P. Manns – 22 February 2007 – Hepatitis B vaccination after liver transplantation for hepatitis B–related liver disease has been investigated as an alternative strategy to reinfection prophylaxis with hepatitis B immunoglobulin (HBIG) with conflicting results. In most studies, HBIG treatment was discontinued before vaccination.

Tanja Bauer, Matthias Günther, Ulrich Bienzle, Ruth Neuhaus, Wolfgang Jilg – 22 February 2007 – After liver transplantation for hepatitis‐B‐related diseases, patients currently receive lifelong treatment with hepatitis B immunoglobulin to prevent endogenous reinfection with hepatitis B virus (HBV). Active immunization with hepatitis B vaccine would be a preferable alternative; however, most attempts to immunize these patients with standard vaccine have failed.